Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ALKS 9072 (Also Known as Aripiprazole Lauroxil, ALKS 9070, or ARISTADA) in Subjects With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial results evaluate the efficacy and safety of ALKS 9072 (aripiprazole lauroxil; ARISTADA) in adults with schizophrenia; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• ALKS 9072 (aripiprazole lauroxil)
• ARISTADA (ARIPIPRAZOLE LAUROXIL)

Snippet

Sponsor: Alkermes, Inc. | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2016-01-22